Herbal and traditional Chinese medicine for the treatment of cardiovascular complications in diabetes mellitus

Current Diabetes Reviews

Volumn 4, Issue 4, 2008, Pages 320-328

  Ceylan Isik, Asli F ^a,b   Fliethman, Rochelle M ^a   Wold, Loren E ^c   Ren, Jun ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b ANKARA UNIVERSITY   (Turkey)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alternative medicine; Cardiovascular; Diabetes; Herbal; Traditional Chinese medicine

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACHYRANTHES BIDENTATA EXTRACT; ANEMARRHENA ASPHODELOIDES EXTRACT; ASTRAGALUS EXTRACT; ATRACTYLODES MACROCEPHALA EXTRACT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPLEURUM ROOT EXTRACT; CALCIUM ANTAGONIST; CINNAMOMUM CASSIA EXTRACT; COPTIS CHINENSIS EXTRACT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GARLIC EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSE; INSULIN; METFORMIN; MOMORDICA CHARANTIA EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PLACEBO; PLANT EXTRACT; ROSIGLITAZONE; SALACIA OBLANGA EXTRACT; SPIRONOLACTONE; SULFONYLUREA DERIVATIVE; SYZYGIUM CUMINI EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTIDIABETIC AGENT; PLANT MEDICINAL PRODUCT;

ACUPUNCTURE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATARACT; CAUSE OF DEATH; CHINESE MEDICINE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIET RESTRICTION; DIET THERAPY; DRUG SAFETY; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; EXERCISE; GLYCEMIC CONTROL; HEART INFARCTION; HERBAL MEDICINE; HUMAN; IMMUNOSTIMULATION; INHIBITION KINETICS; LIFESTYLE MODIFICATION; MORBIDITY; MOXIBUSTION; NONHUMAN; PATIENT ATTITUDE; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SALACIA; SALACIA OBLANGA; SMOKING CESSATION; TAI CHI; TRADITIONAL MEDICINE; TUI NA; WEIGHT CONTROL; DIABETIC ANGIOPATHY; ENERGY METABOLISM; FATIGUE; GINKGO BILOBA; METHODOLOGY; PHYTOTHERAPY; PLANT ROOT;

CARDIOVASCULAR DISEASES; DIABETIC ANGIOPATHIES; ENERGY METABOLISM; FATIGUE; GINKGO BILOBA; HERBAL MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS; MEDICINE, CHINESE TRADITIONAL; PHYTOTHERAPY; PLANT PREPARATIONS; PLANT ROOTS; YIN-YANG;

EID: 59849117369     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339908786241142     Document Type: Review

References (108)

1. Wold LE, Ceylan-Isik AF, Ren J. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy. Acta Pharmacol Sin 2005; 26(8): 908-17.
2. Lebovitz HE. Etiology and pathogenesis of diabetes mellitus. Pediatr Clin North Am 1984; 31(3): 521-30.
3. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985; 27(4): 255-70.
4. Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes. Am J Physiol 1997; 272(1 Pt 2): H148-H158.
5. Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine 2004; 25(2): 73-83.
6. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Cardiovasc Drugs Ther 1994; 8(1): 65-73.
7. Buyukgebiz A, Saylam G, Dundar B, Bober E, Unal N, Akcoral A. Dilated cardiomyopathy as the first early complication in a 14 year-old girl with diabetes mellitus type 1. J Pediatr Endocrinol Metab 2000; 13(8): 1143-6.
8. Li SY, Yang X, Ceylan-Isik AF, Du M, Sreejayan N, Ren J. Cardiac contractile dysfunction in Lep/Lep obesity is accompanied by NADPH oxidase activation, oxidative modification of sarco(endo)plasmic reticulum Ca2+-ATPase and myosin heavy chain isozyme switch. Diabetologia 2006; 49(6): 1434-46.
9. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001; 24(1): 5-10.
10. Royle PL, Bain L, Waugh NR. Sources of evidence for systematic reviews of interventions in diabetes. Diabet Med 2005; 22(10): 1386-93.
11. Gizard F, Bruemmer D. Transcriptional control of vascular smooth muscle cell proliferation by peroxisome proliferator-activated receptor-gamma: Therapeutic implications for cardiovascular diseases. PPAR Res 2008; 2008: 429123.
12. Li S, Culver B, Ren J. Benefit and risk of exercise on myocardial function in diabetes. Pharmacol Res 2003; 48(2): 127-32.
13. Lincoff AM, Wolski K, Nicholls SJ, Nissen SE. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA 2007; 298(10): 1180-8.
14. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356(24): 2457-71.
15. Eurich DT, Majumdar SR. Review: Thiazolidinediones increase congestive heart failure but not cardiovascular deaths in prediabetes or type 2 diabetes. ACP J Club 2008; 148(2): 39.
16. Dandona P, Chaudhuri A. Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death? Nat Clin Pract Cardiovasc Med 2008; 5(5): 244-5.
17. Scheen AJ. Do thiazolidinediones increase the risk of congestive heart failure and cardiovascular death? Nat Clin Pract Endocrinol Metab 2008; 4(5): 260-1.
18. Alarcon-Aguilara FJ, Roman-Ramos R, Perez-Gutierrez S, Aguilar-Contreras A, Contreras-Weber CC, Flores-Saenz JL. Study of the anti-hyperglycemic effect of plants used as anti-diabetics. J Ethnopharmacol 1998; 61(2): 101-10.
19. Al Rowais NA. Herbal medicine in the treatment of diabetes mellitus. Saudi Med J 2002; 23(11): 1327-31.
20. Dey L, Attele AS, Yuan CS. Alternative therapies for type 2 diabetes. Altern Med Rev 2002; 7(1): 45-58.
21. Kar A, Choudhary BK, Bandyopadhyay NG. Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. J Ethnopharmacol 2003; 84(1): 105-8.
22. Kar A, Choudhary BK, Bandyopadhyay NG. Preliminary studies on the inorganic constituents of some indigenous hypoglycaemic herbs on oral glucose tolerance test. J Ethnopharmacol 1999; 64(2): 179-84.
23. Jafri MA, Aslam M, Javed K, Singh S. Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan-induced diabetic rats. J Ethnopharmacol 2000; 70(3): 309-14.
24. Bailey CJ, Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989; 12(8): 553-64.
25. Cheng TO. Cardiovascular effects of Danshen. Int J Cardiol 2007; 121(1): 9-22.
26. Wang ZG, Ren J. Pharmacology and toxicology of traditional Chinese medicines: a historical perspective. In: Current Problems in Nutrition, Pharmacology and Toxicology. McLean A, Wahlqvist ML, Eds: 1st ed. John Libbey & Company Limited Press, London 1988; vol. 1, (1-2): 44-9.
27. Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am J Chin Med 2007; 35(4): 543-58.
28. Everitt AV, Hilmer SN, Brand-Miller JC, et al. Dietary approaches that delay age-related diseases. Clin Interv Aging 2006; 1(1): 11-31.
29. Radad K, Gille G, Liu L, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006; 100(3): 175-86.
30. Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides Rb1 and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol 2001; 134(6): 1159-65.
31. Deyama T, Nishibe S, Nakazawa Y. Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin 2001; 22(12): 1057-70.
32. Lei H, Wang B, Li WP, Yang Y, Zhou AW, Chen MZ. Anti-aging effect of astragalosides and its mechanism of action. Acta Pharmacol Sin 2003; 24(3): 230-4.
33. Inoue S, Koya-Miyata S, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Royal Jelly prolongs the life span of C3H/HeJ mice: correlation with reduced DNA damage. Exp Gerontol 2003; 38(9): 965-9.
34. Bittles AH, Fulder SJ, Grant EC, Nicholls MR. The effect of ginseng on lifespan and stress responses in mice. Gerontology 1979; 25(3): 125-31.
35. Cho WC, Leung KN. In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 2007; 113(1): 132-41.
36. Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 2007; 252(1): 43-54.
37. Zhang Q, Kang X, Zhao W. Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma. Biochem Biophys Res Commun 2006; 342(3): 824-8.
38. Oshiro S, Fukushima T, Tomonaga M, Black KL. Antitumor activity and modified immunoregulation associated with IFN-gamma treatment of RG2 gliomas. Anticancer Res 1999; 19(6B): 5029-36.
39. Kwon HS, Oh SM, Kim JK. Glabridin, a functional compound of liquorice, attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol 2008; 151(1): 165-73.
40. Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 2002; 9(2): 145-50.
41. Wu F, Chen X. [A review of pharmacological study on Astragalus membranaceus (Fisch.) Bge.]. Zhong Yao Cai 2004; 27(3): 232-4.
42. Tachikawa E, Kudo K. Proof of the mysterious efficacy of ginseng: basic and clinical trials: suppression of adrenal medullary function in vitro by ginseng. J Pharmacol Sci 2004; 95(2): 140-4.
43. Chien SC, Larson E, Nakamura N, Lin SJ. Self-care problems of adolescents with type 1 diabetes in southern Taiwan. J Pediatr Nurs 2007; 22(5): 404-9.
44. Xie JT, Mchendale S, Yuan CS. Ginseng and diabetes. Am J Chin Med 2005; 33(3): 397-404.
45. Maffei FR, Carini M, Aldini G, Berti F, Rossoni G. Panax ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention. Planta Med 1999; 65(7): 614-9.
46. Li JX, Xue B, Chai Q, Liu ZX, Zhao AP, Chen LB. Antihypertensive effect of total flavonoid fraction of Astragalus complanatus in hypertensive rats. Chin J Physiol 2005; 48(2): 101-6.
47. Zhou XM, Cao YL, Dou DQ. Protective effect of ginsenoside-Re against cerebral ischemia/reperfusion damage in rats. Biol Pharm Bull 2006; 29(12): 2502-5.
48. Guan L, Li W, Liu Z. Effect of ginsenoside-Rb1 on cardiomyocyte apoptosis after ischemia and reperfusion in rats. J Huazhong Univ Sci Technol Med Sci 2002; 22(3): 212-5.
49. Qian JJ. Effects of a ginseng injection compound on platelet aggregation and release. J Beijing Trad Chin Med Coll 1984; 7(9): 26-30.
50. Huang WH, Song CQ. [Research progresses in the chemistry and pharmacology of Angelica sinensis (Oliv.) Diel]. Zhongguo Zhong Yao Za Zhi 2001; 26(3): 147-51, 155.
51. Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 2007; 117(2): 280-95.
52. Wu CF. [A review on the pharmacology of Paeonia lactiflora and its chemical components]. ZhongYao Tong Bao 1985; 10(6): 43-5.
53. Rodriguez-Cruz M, Tovar AR, del Prado M, Torres N. [Molecular mechanisms of action and health benefits of polyunsaturated fatty acids]. Rev Invest Clin 2005; 57(3): 457-72.
54. Sun J, Huang SH, Tan BK, et al. Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. Life Sci 2005; 76(24): 2849-60.
55. Yu XC, Wu S, Chen CF, Pang KT, Wong TM. Antihypertensive and anti-arrhythmic effects of an extract of Radix Stephaniae Tetrandrae in the rat. J Pharm Pharmacol 2004; 56(1): 115-22.
56. Wong TM, Wu S, Yu XC, Li HY. Cardiovascular actions of Radix Stephaniae Tetrandrae: a comparison with its main component, tetrandrine. Acta Pharmacol Sin 2000; 21(12): 1083-8.
57. Wang J, Shi YM, Zheng HM. [Experimental study of Ligusticum wallichii on cerebrovascular hemodynamic parameters]. Zhongguo Zhong Xi Yi Jie He Za Zhi 1993; 13(7): 417-9, 389.
58. Soma M, Manku MS, Jenkins DK, Huang YS, Horrobin DF. Effects of dietary saturated, N-6 and N-3 polyunsaturated fats on blood pressure and prostaglandins outflow from perfused mesenteric vascular bed in rats. Prostaglandins 1985; 30(6): 969-80.
59. Guo JY, Wang SY. Experimental studies on portal pressure decreasing effects of Paeonia lactiflora. Chin J Digest 1997; 1(6): 111-4.
60. Ma YJ. Protective effects of Ligusticum Wellichi active components on glycerol induced acute renal failure in rabbit. Chin J Urol 1982; 3(6): 11-4.
61. Weng WL. A comparative study on the effect of 20 herbs activating blood circulation and decreasing blood stasis on the obstruction of experimental microcirculation. Chin J Integ Trad Western Med 1984; 4(3): 555-7.
62. Hu WS, Pang XD, Wang Y. Effects of Tetrandrine on vascular smooth muscle. J Trad Chin Med 1982; 23(9): 67-71.
63. Li CZ, Yang SC, Zhao FD. The effect of yimucao, chishao, danggui, sanleng, erzhu and zelan on blood coagulation in rats. Chin J Integr Trad Western Med 1982; 2(6): 111-2.
64. Shi QH. Effects of "Coronary Heart II" on the release of serotonin and the ultrastructure of rabbit platelets. Chin J Integr Trad Western Med 1981; 1(6): 90-2.
65. Weng WL. The effect of d-catechin on the rheology of blood in patients with coronary heart disease. Bull Chin Mater Med 1984; 9(4): 38-41.
66. Jia W, Gao WY, Xiao PG. Antidiabetic drugs of plant origin used in China: compositions, pharmacology, and hypoglycemic mechanisms. Zhongguo ZhongYao Za Zhi 2003; 28(2): 108-13.
67. Jia W, Gao W, Tang L. Antidiabetic herbal drugs officially approved in China. Phytother Res 2003; 17(10): 1127-34.
68. Cheng TO. Panax (ginseng) is not a panacea. Arch Intern Med 2000; 160(21): 3329-1.
69. Everitt AV, Hilmer SN, Brand-Miller JC, et al. Dietary approaches that delay age-related diseases. Clin Interv Aging 2006; 1(1): 11-31.
70. Xie JT, Aung HH, Wu JA, Attel AS, Yuan CS. Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med 2002; 30(2-3): 187-94.
71. Xie JT, Zhou YP, Dey L, et al. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 2002; 9(3): 254-8.
72. Xie JT, Wang CZ, Ni M, et al. American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. J Food Sci 2007; 72(8): S590-S594
73. Reay JL, Kennedy DO, Scholey AB. The glycaemic effects of single doses of Panax ginseng in young healthy volunteers. Br J Nutr 2006; 96(4): 639-42.
74. Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002; 51(6): 1851-8.
75. Wang ZG, Ren J. Current status and future direction of Chinese herbal medicine. Trends Pharmacol Sci 2002; 23(8): 347-8.
76. Yun TK. Panax ginseng - a non-organ-specific cancer preventive? Lancet Oncol 2001; 2(1): 49-55.
77. Chang HK, Jang MH, Lim BV, et al. Administration of Ginseng radix decreases nitric oxide synthase expression in the hippocampus of streptozotocin-induced diabetic rats. Am J Chin Med 2004; 32(4): 497-507.
78. Esberg LB, Ren J. Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes. Diabetologia 2003; 46(10): 1419-27.
79. Cho WC, Chung WS, Lee SK, Leung AW, Cheng CH, Yue KK. Ginsenoside Re of Panax ginseng possesses significant antioxidant and antihyperlipidemic efficacies in streptozotocin-induced diabetic rats. Eur J Pharmacol 2006; 550(1-3): 173-9.
80. Xie JT, Wu JA, Mehendale S, Aung HH, Yuan CS. Anti-hyperglycemic effect of the polysaccharides fraction from American ginseng berry extract in ob/ob mice. Phytomedicine 2004; 11(2-3): 182-7.
81. Xie JT, Mehendale SR, Wang A, et al. American ginseng leaf: ginsenoside analysis and hypoglycemic activity. Pharmacol Res 2004; 49(2): 113-7.
82. Dodge HH, Zitzelberger T, Oken BS, Howieson D, Kaye J. A randomized placebo-controlled trial of ginkgo biloba for the prevention of cognitive decline. Neurology 2008; 70(19pt2): 1809-17.
83. Welt K, Weiss J, Koch S, Fitzl G. Protective effects of Ginkgo biloba extract EGb 761 on the myocardium of experimentally diabetic rats. II. Ultrastructural and immunohistochemical investigation on microvessels and interstitium. Exp Toxicol Pathol 1999; 51(3): 213-22.
84. Fitzl G, Martin R, Dettmer D, Hermsdorf V, Drews H, Welt K. Protective effects of Gingko biloba extract EGb 761 on myocardium of experimentally diabetic rats. I: ultrastructural and biochemical investigation on cardiomyocytes. Exp Toxicol Pathol 1999; 51(3): 189-98.
85. Grover JK, Vats V, Rathi SS. Anti-hyperglycemic effect of Eugenia jambolana and Tinospora cordifolia in experimental diabetes and their effects on key metabolic enzymes involved in carbohydrate metabolism. J Ethnopharmacol 2000; 73(3): 461-70.
86. Rathi SS, Grover JK, Vats V. The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism. Phytother Res 2002; 16(3): 236-43.
87. Grover JK, Vats V, Rathi SS, Dawar R. Traditional Indian antidiabetic plants attenuate progression of renal damage in streptozotocin induced diabetic mice. J Ethnopharmacol 2001; 76(3): 233-8.
88. Rathi SS, Grover JK, Vikrant V, Biswas NR. Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytother Res 2002; 16(8): 774-7.
89. Grover JK, Rathi SS, Vats V. Amelioration of experimental diabetic neuropathy and gastropathy in rats following oral administration of plant (Eugenia jambolana, Mucuna pruriens and Tinospora cordifolia) extracts. Indian J Exp Biol 2002; 40(3): 273-6.
90. Davis RH, Maro NP. Aloe vera and gibberellin. Anti-inflammatory activity in diabetes. J Am Podiatr Med Assoc 1989; 79(1): 24-6.
91. Chithra P, Sajithlal GB, Chandrakasan G. Influence of aloe vera on the healing of dermal wounds in diabetic rats. J Ethnopharmacol 1998; 59(3): 195-201.
92. Li Y, Peng G, Li Q, et al. Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese Zucker rats. Life Sci 2004; 75(14): 1735-46.
93. Shimizu M, Umeda K, Sugihara N, et al. Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 1993; 46(1): 32-6.
94. Lebovitz HE. Effect of the postprandial state on nontraditional risk factors. Am J Cardiol 2001; 88(6A): 20H-5H.
95. Heine RJ, Dekker JM. Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease. Diabetologia 2002; 45(4): 461-75.
96. Li C, Cao L, Zeng Q. Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type2 receptors' expression. J Huazhong Univ Sci Technol Med Sci 2004; 24(4): 379-84.
97. Brown L, Sernia C. Angiotensin receptors in cardiovascular diseases. Clin Exp Pharmacol Physiol 1994; 21(10): 811-8.
98. Gebhardt R. Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 1993; 28(7): 613-9.
99. Sendl A, Schliack M, Loser R, Stanislaus F, Wagner H. Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic. Atherosclerosis 1992; 94(1): 79-85.
100. Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993; 119(7 Pt 1): 599-605.
101. Kleijnen J, Knipschild P, ter Riet G. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol 1989; 28(5): 535-44.
102. Patumraj S, Tewit S, Amatyakul S, et al. Comparative effects of garlic and aspirin on diabetic cardiovascular complications. Drug Deliv 2000; 7(2): 91-6.
103. Jain RC, Vyas CR. Garlic in alloxan-induced diabetic rabbits. Am J Clin Nutr 1975; 28(7): 684-5.
104. Ashraf R, Aamir K, Shaikh AR, Ahmed T. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J Ayub Med Coll Abbottabad 2005; 17(3): 60-4.
105. Kleijnen J, Knipschild P, ter Riet G. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J Clin Pharmacol 1989; 28(5): 535-44.
106. Kendler BS. Garlic (Allium sativum) and onion (Allium cepa): a review of their relationship to cardiovascular disease. Prev Med 1987; 16(5): 670-85.
107. Al Amin ZM, Thomson M, Al Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr 2006; 96(4): 660-6.
108. Huang TH, Kota BP, Razmovski V, Roufogalis BD. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol 2005; 96(1): 3-14.